Events Partner Content 15th Annual Pre-Filled Syringes and Injectable Drug Devices ... The Future of Drug Delivery and Combination Products
Partner Content Partner Content Registration opens for Pre-filled Syringes & Injectable Devi... Registration opens for Pre-filled Syringes Conference
Partner Content Partner Content Developing custom syringes for highly viscous formulations d... Developing custom syringes for highly viscous formulati
Partner Content Partner Content Jace Blackburn, Smart Device Engineer, Genentech presents at... Smart Device Engineer presents at PFS San Francisco
Partner Content Partner Content Notified Body BSi Group to lead workshop during Pre-filled S... Notified Body BSi Group to lead workshop
Partner Content Partner Content Chair letter released for SMi Group’s Pre-filled Syringes Sa... Chair letter released for Pre-filled Syringes San Fran
News Otsuka eyes early filing of IgAN drug after phase 3 readout Otsuka is hoping to file for approval of its anti-APRIL antibody sibeprenlimab as a treatment for kidney disorder IgA nephropathy (IgAN) after the drug hit the target in a phase 3 trial.
Sales & Marketing Sponsored Global reach, personal touch: Mastering customer engagement ... In today's interconnected pharma market, the ability to scale engagement across borders is essential for survival and growth.